Press Release: Santhera Announces Preliminary -2-

eva.kalias@santhera.com https://www.globenewswire.com/Tracker?data=nvz_PsygNKy6vw7hgg2zs8oZU0OznCCbhgQ3uj1Q1vYr9YUqdQ0TH_pH7tWuXCj_9p7dCZ45i2ibhS9OqNaRrZkzaO5zs1VNcv8qRf9tXmM=

Disclaimer / Forward-looking statements

This communication does not constitute an offer or invitation to subscribe for or purchase any securities of Santhera Pharmaceuticals Holding AG. This publication may contain certain forward-looking statements concerning the Company and its business. Such statements involve certain risks, uncertainties and other factors which could cause the actual results, financial condition, performance or achievements of the Company to be materially different from those expressed or implied by such statements. Readers should therefore not place undue reliance on these statements, particularly not in connection with any contract or investment decision. The Company disclaims any obligation to update these forward-looking statements.

# # #

Attachment

-- 2022 09 29_H12022_prelim_e_final

https://ml-eu.globenewswire.com/Resource/Download/f186e144-69bc-48c7-871c-9a5eac59e7a3

(END) Dow Jones Newswires

September 29, 2022 01:00 ET (05:00 GMT)